FGFR1 Promotes Malignant Progression in Lung Squamous Cell Carcinoma Through Activation of Wnt/β‐Catenin Signaling
Cancer Medicine · 2026
DOI: 10.1002/cam4.71833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Xingyuan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School o…. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Wnt Signaling Pathway, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
This study aims to elucidate the role of FGFR1 in activating the Wnt/β‐catenin signaling pathway and the underlying mechanisms by which it promotes malignant progression in lung squamous cell carcinoma (LUSC). By integrating multi‐omics analysis with functional experiments, the clinical heterogeneity of FGFR1 amplification, signaling crosstalk, and their regulatory networks governing tumor phenotypes were revealed.
Methods
Using TCGA data ( n = 490), we analyzed the relationship between FGFR1 copy number variation (CNV) and mRNA expression in LUSC, and validated the correlation with protein expression in a clinical cohort ( n = 38). GSEA and single‐gene GSEA were performed to identify signaling pathways associated with high FGFR1 expression. The interaction between FGFR1 and the Wnt/β‐catenin pathway was investigated by immunohistochemistry, immunofluorescence, stable cell lines, Western blot, qPCR, and functional assays.
Results
FGFR1 amplification correlated with increased mRNA and protein expression. The top 25% FGFR1 high‐expression group enriched Wnt/β‐catenin, PI3K‐Akt, and cAMP pathways. Mechanistically, FGFR1 promoted β‐catenin nuclear accumulation and enhanced β‐catenin signaling through PKA‐associated phosphorylation and Akt/GSK3β‐related regulation of β‐catenin stability, and these effects were attenuated by AKT inhibition. CTNNB1 knockdown significantly inhibited proliferation, migration, invasion, and tumor growth of LUSC cells.
Conclusions
Our findings indicate that FGFR1 activates Wnt/β‐catenin signaling through coordinated regulation of β‐catenin phosphorylation, stability, and subcellular localization, thereby promoting malignant progression in LUSC. These results provide a rationale for targeting the FGFR1‐Wnt/β‐catenin axis as a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Yongfeng Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Mu, S., Sun, Y., & Yu, Y. (2026). FGFR1 Promotes Malignant Progression in Lung Squamous Cell Carcinoma Through Activation of Wnt/β‐Catenin Signaling. Cancer Medicine. https://doi.org/10.1002/cam4.71833
Vancouver
Li X, Mu S, Sun Y, Yu Y. FGFR1 Promotes Malignant Progression in Lung Squamous Cell Carcinoma Through Activation of Wnt/β‐Catenin Signaling. Cancer Medicine. 2026. doi:10.1002/cam4.71833
BibTeX
@article{Li2026,
author = {Li, Xingyuan and Mu, Shuya and Sun, Yinjia and Yu, Yongfeng},
title = {FGFR1 Promotes Malignant Progression in Lung Squamous Cell Carcinoma Through Activation of Wnt/β‐Catenin Signaling},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71833}
}
EUVIMED